A single institution, retrospective study assessing the predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with CRT followed by consolidative Durvalumab
Latest Information Update: 17 Nov 2021
At a glance
- Drugs Durvalumab (Primary) ; Carboplatin; Cisplatin; Etoposide
- Indications Adenocarcinoma; Non-small cell lung cancer; Squamous cell cancer
- Focus Adverse reactions
- 17 Nov 2021 New trial record
- 21 Sep 2021 Results presented at the 46th European Society for Medical Oncology Congress